Pharmaceutical companies to implement electronic medication registration by March
Technical details
Summary
Royal Decree 468/2026 amends RD 1345/2007 to require electronic registration of industrially produced human medicines. A new Additional Provision 7 sets a three-month implementation period from the decree's entry into force, aiming to modernise control and improve product traceability (arts. 81.1, 84-86, disp. ad. 7).
Lifecycle
BMC resources for this provision
- business-lawView service →